Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ·Healthcare·Biotechnology
$8.66
-0.86%
Mkt Cap $1.34B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$8.82
Range $4.00 – $18.00
Implied Upside
+1.9%
Consensus $8.82 vs current $8.66
NASDAQ·Healthcare·Biotechnology
$8.66
-0.86%
Mkt Cap $1.34B
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$8.82
Range $4.00 – $18.00
+1.9%
Consensus $8.82 vs current $8.66